{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:07:29Z","timestamp":1789592849912,"version":"build-2803163510"},"reference-count":75,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Immunogenic cell death (ICD) has emerged as a novel option for cancer immunotherapy. The key determinants of ICD encompass antigenicity (the presence of antigens) and adjuvanticity, which involves the release of damage-associated molecular patterns (DAMPs) and various cytokines and chemokines. CX3CL1, also known as neurotactin or fractalkine, is a chemokine involved in cellular signalling and immune cell interactions. CX3CL1 has been denoted as a \u201cfind me\u201d signal that stimulates chemotaxis of immune cells towards dying cells, facilitating efferocytosis and antigen presentation. However, in the context of ICD, it is uncertain whether CX3CL1 is an important mediator of the effects of ICD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this study, we investigated the intricate role of CX3CL1 in immunogenic apoptosis induced by mitoxantrone (MTX) in cancer cells. The Luminex xMAP technology was used to quantify murine cytokines, chemokines and growth factors to identify pivotal regulatory cytokines released by murine fibrosarcoma MCA205 and melanoma B16-F10 cells undergoing ICD. Moreover, a murine tumour prophylactic vaccination model was employed to analyse the effect of CX3CL1 on the activation of an adaptive immune response against MCA205 cells undergoing ICD. Furthermore, thorough analysis of the TCGA-SKCM public dataset from 98 melanoma patients revealed the role of CX3CL1 and its receptor CX3CR1 in melanoma patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Our findings demonstrate enhanced CX3CL1 release from apoptotic MCA205 and B16-F10 cells (regardless of the cell type) but not if they are undergoing ferroptosis or accidental necrosis. Moreover, the addition of recombinant CX3CL1 to non-immunogenic doses of MTX-treated, apoptotically dying cancer cells in the murine prophylactic tumour vaccination model induced a robust immunogenic response, effectively increasing the survival of the mice. Furthermore, analysis of melanoma patient data revealed enhanced survival rates in individuals exhibiting elevated levels of CD8+ T cells expressing CX3CR1.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>These data collectively underscore the importance of the release of CX3CL1 in eliciting an immunogenic response against dying cancer cells and suggest that CX3CL1 may serve as a key switch in conferring immunogenicity to apoptosis.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2024.1396349","type":"journal-article","created":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T04:46:21Z","timestamp":1719809181000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["CX3CL1 release during immunogenic apoptosis is associated with enhanced anti-tumour immunity"],"prefix":"10.3389","volume":"15","author":[{"given":"Faye","family":"Naessens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Demuynck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Vershinina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iuliia","family":"Efimova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariia","family":"Saviuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greet","family":"De Smet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana A.","family":"Mishchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria V.","family":"Vedunova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Krysko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Catanzaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitri V.","family":"Krysko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000337","article-title":"Consensus guidelines for the definition, detection and interpretation of immunogenic cell death","volume":"8","author":"Galluzzi","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20050915","article-title":"Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death","volume":"202","author":"Casares","year":"2005","journal-title":"J Exp Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.03.037","article-title":"Vaccination with necroptotic cancer cells induces efficient anti-tumor immunity","volume":"15","author":"Aaes","year":"2016","journal-title":"Cell Rep"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1900072","article-title":"Immunodominant AH1 antigen-deficient necroptotic, but not apoptotic, murine cancer cells induce antitumor protection","volume":"204","author":"Aaes","year":"2020","journal-title":"J Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad0395","article-title":"RIPK1 and NF-\u03baB signaling in dying cells determines cross-priming of CD8+ T cells","volume":"350","author":"Yatim","year":"2015","journal-title":"Science"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001369","article-title":"Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity","volume":"8","author":"Efimova","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2021.2008692","article-title":"DCN released from ferroptotic cells ignites AGER-dependent immune responses","volume":"18","author":"Liu","year":"2022","journal-title":"Autophagy"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2024.01.013","article-title":"Immunogenicity of ferroptosis in cancer: a matter of context","volume":"10","author":"Catanzaro","year":"2024","journal-title":"Trends Cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1591875","DOI":"10.1080\/2162402X.2019.1591875","article-title":"Oncolytic virus immunotherapy induces immunogenic cell death and overcomes STING deficiency in melanoma","volume":"8","author":"Bommareddy","year":"2019","journal-title":"Oncoimmunology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/nm1523","article-title":"Calreticulin exposure dictates the immunogenicity of cancer cell death","volume":"13","author":"Obeid","year":"2007","journal-title":"Nat Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2057892","DOI":"10.1080\/2162402X.2022.2057892","article-title":"Carbon ion radiotherapy triggers immunogenic cell death and sensitizes melanoma to anti-PD-1 therapy in mice","volume":"11","author":"Zhou","year":"2022","journal-title":"OncoImmunology"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12572","article-title":"Immunomodulation by ionizing radiation-impact for design of radio-immunotherapies and for treatment of inflammatory diseases","volume":"280","author":"Frey","year":"2017","journal-title":"Immunol Rev"},{"key":"B13","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1186\/s40425-019-0826-3","article-title":"Immunogenic cell death induced by a new photodynamic therapy based on photosens and photodithazine","volume":"7","author":"Turubanova","year":"2019","journal-title":"J Immunother Cancer"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/332462a0","article-title":"The presence of malfolded proteins in the endoplasmic reticulum signals the induction of glucose-regulated proteins","volume":"332","author":"Kozutsumi","year":"1988","journal-title":"Nature"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2104551","DOI":"10.1080\/2162402X.2022.2104551","article-title":"Schweinfurthin induces ICD without ER stress and caspase activation","volume":"11","author":"Zhang","year":"2022","journal-title":"OncoImmunology"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2019.00050","article-title":"Immunogenic cell death and immunotherapy of multiple myeloma","volume":"7","author":"Serrano-del Valle","year":"2019","journal-title":"Front Cell Dev Biol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.3390\/cells11182899","article-title":"The \u201cYin and yang\u201d of unfolded protein response in cancer and immunogenic cell death","volume":"11","author":"Rufo","year":"2022","journal-title":"Cells januari"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.3390\/cells11223705","article-title":"In vitro veritas: from 2D cultures to organ-on-a-chip models to study immunogenic cell death in the tumor microenvironment","volume":"11","author":"Krysko","year":"2022","journal-title":"Cells januari"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003430","article-title":"Immunogenic ferroptosis and where to find it","volume":"9","author":"Demuynck","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B20","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","article-title":"Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018","volume":"25","author":"Galluzzi","year":"2018","journal-title":"Cell Death Differ"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3380","article-title":"Immunogenic cell death and DAMPs in cancer therapy","volume":"12","author":"Krysko","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"B22","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nri.2016.107","article-title":"Immunogenic cell death in cancer and infectious disease","volume":"17","author":"Galluzzi","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/42491","article-title":"Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation","volume":"387","author":"Pan","year":"1997","journal-title":"Nature"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80438-9","article-title":"Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion","volume":"91","author":"Imai","year":"1997","journal-title":"Cell"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3723","DOI":"10.3390\/ijms21103723","article-title":"Fractalkine\/CX3CL1 in neoplastic processes","volume":"21","author":"Korbecki","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.15.10053","article-title":"Molecular uncoupling of fractalkine-mediated cell adhesion and signal transduction: RAPID FLOW ARREST OF CX3CR1-EXPRESSING CELLS IS INDEPENDENT OF G-PROTEIN ACTIVATION *","volume":"274","author":"Haskell","year":"1999","journal-title":"J Biol Chem"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.20.11.4106-4114.2000","article-title":"Analysis of fractalkine receptor CX3CR1 function by targeted deletion and green fluorescent protein reporter gene insertion","volume":"20","author":"Jung","year":"2000","journal-title":"Mol Cell Biol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M106434200","article-title":"Tumor necrosis factor-\u03b1-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1) *","volume":"276","author":"Garton","year":"2001","journal-title":"J Biol Chem"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/PL00000230","article-title":"Fractalkine induces chemotaxis and actin polymerization in human dendritic cells","volume":"50","author":"Dichmann","year":"2001","journal-title":"Inflamm Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-06-162404","article-title":"CX3CL1\/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis","volume":"112","author":"Truman","year":"2008","journal-title":"Blood"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/385640a0","article-title":"A new class of membrane-bound chemokine with a CX3C motif","volume":"385","author":"Bazan","year":"1997","journal-title":"Nature"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2014.00360","article-title":"Fractalkine is a \u201cfind-me\u201d signal released by neurons undergoing ethanol-induced apoptosis","volume":"8","author":"Sokolowski","year":"2014","journal-title":"Front Cell Neurosci"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M706586200","article-title":"Migration to apoptotic \u201cFind-me\u201d Signals is mediated via the phagocyte receptor G2A *","volume":"283","author":"Peter","year":"2008","journal-title":"J Biol Chem"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.2119\/2007-00019.Miksa","article-title":"Fractalkine-induced MFG-E8 leads to enhanced apoptotic cell clearance by macrophages","volume":"13","author":"Miksa","year":"2007","journal-title":"Mol Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.3390\/cells10102583","article-title":"CX3CL1(+) microparticles-induced MFG-E8 enhances apoptotic cell clearance by alveolar macrophages","volume":"10","author":"Tsai","year":"2021","journal-title":"Cells"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2015.4438","article-title":"Upregulation of fractalkine contributes to the proliferative response of prostate cancer cells to hypoxia via promoting the G1\/S phase transition","volume":"12","author":"Tang","year":"2015","journal-title":"Mol Med Rep"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-3828","article-title":"CX3CL1 promotes breast cancer via transactivation of the EGF pathway","volume":"73","author":"Tard\u00e1guila","year":"2013","journal-title":"Cancer Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/cbf.3278","article-title":"Fractalkine\/CX3CR1 induces apoptosis resistance and proliferation through the activation of the AKT\/NF-\u03baB cascade in pancreatic cancer cells","volume":"35","author":"Wang","year":"2017","journal-title":"Cell Biochem Funct"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3892\/ijo","article-title":"CX3CL1\/fractalkine enhances prostate cancer spinal metastasis by activating the Src\/FAK pathway","volume":"53","author":"Liu","year":"2018","journal-title":"Int J Oncol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2016.456","article-title":"Emergent role of the fractalkine axis in dissemination of peritoneal metastasis from epithelial ovarian carcinoma","volume":"36","author":"Gurler Main","year":"2017","journal-title":"Oncogene"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.11250","article-title":"Fractalkine\/CX3CL1 induced intercellular adhesion molecule-1-dependent tumor metastasis through the CX3CR1\/PI3K\/Akt\/NF-\u03baB pathway in human osteosarcoma","volume":"8","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.7150\/jca.26497","article-title":"CX3CL1 involves in breast cancer metastasizing to the spine via the Src\/FAK signaling pathway","volume":"9","author":"Liang","year":"2018","journal-title":"J Cancer"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2017.05.024","article-title":"Cytokines in immunogenic cell death: Applications for cancer immunotherapy","volume":"97","author":"Showalter","year":"2017","journal-title":"Cytokine"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.30770","article-title":"The cross-talk between soluble \u201cFind me\u201d and \u201cKeep out\u201d signals as an initial step in regulating efferocytosis","volume":"237","author":"Tajbakhsh","year":"2022","journal-title":"J Cell Physiol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.4161\/onci.28473","article-title":"Screening of novel immunogenic cell death inducers within the NCI Mechanistic Diversity Set","volume":"3","author":"Sukkurwala","year":"2014","journal-title":"OncoImmunology"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btz363","article-title":"Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology","volume":"35","author":"Sturm","year":"2019","journal-title":"Bioinformatics"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.26476.049","article-title":"Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data","volume":"6","author":"Racle","year":"2017","journal-title":"eLife"},{"key":"B48","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13059-016-1028-7","article-title":"Comprehensive analyses of tumor immunity: implications for cancer immunotherapy","volume":"17","author":"Li","year":"2016","journal-title":"Genome Biol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13073-019-0638-6","article-title":"Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data","volume":"11","author":"Finotello","year":"2019","journal-title":"Genome Med"},{"key":"B50","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","article-title":"Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression","volume":"17","author":"Becht","year":"2016","journal-title":"Genome Biol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","article-title":"xCell: digitally portraying the tissue cellular heterogeneity landscape","volume":"18","author":"Aran","year":"2017","journal-title":"Genome Biol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2023.12.006","article-title":"Laser-induced vapor nanobubbles for B16-F10 melanoma cell killing and intracellular delivery of chemotherapeutics","volume":"365","author":"Ramon","year":"2024","journal-title":"J Control Release"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.4161\/onci.21098","article-title":"Primary sterile necrotic cells fail to cross-prime CD8+ T cells","volume":"1","author":"Gamrekelashvili","year":"2012","journal-title":"OncoImmunology"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-022-05514-0","article-title":"DC vaccines loaded with glioma cells killed by photodynamic therapy induce Th17 anti-tumor immunity and provide a four-gene signature for glioma prognosis","volume":"13","author":"Vedunova","year":"2022","journal-title":"Cell Death Dis"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2623-z","article-title":"Lymph protects metastasizing melanoma cells from ferroptosis","volume":"585","author":"Ubellacker","year":"2020","journal-title":"Nature"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-019-2143-7","article-title":"Aldo-keto reductases protect metastatic melanoma from ER stress-independent ferroptosis","volume":"10","author":"Gagliardi","year":"2019","journal-title":"Cell Death Dis"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.135343","article-title":"The chemokine CX3CL1 promotes trafficking of dendritic cells through inflamed lymphatics","volume":"126","author":"Johnson","year":"2013","journal-title":"J Cell Sci"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.10816","article-title":"Fractalkine transgene\u00a0induces T-cell-dependent antitumor immunity through chemoattraction\u00a0and activation of dendritic cells","volume":"103","author":"Guo","year":"2003","journal-title":"Int J Cancer"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0165-2478(03)00101-9","article-title":"Chemoattraction, adhesion and activation of natural killer cells are involved in the antitumor immune response induced by fractalkine\/CX3CL1","volume":"89","author":"Guo","year":"2003","journal-title":"Immunol Lett"},{"key":"B60","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/(ISSN)1521-4141","article-title":"Fractalkine receptor expression by T lymphocyte subpopulations and in vivo production of fractalkine in human","volume":"30","author":"Foussat","year":"2000","journal-title":"Eur J Immunol"},{"key":"B61","article-title":"Fractalkine mediates natural killer-dependent antitumor responses in vivo1","volume":"63","author":"Lavergne","year":"2003","journal-title":"Cancer Res"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-12-126888","article-title":"Dendritic cell and natural killer cell cross-talk: a pivotal role of CX3CL1 in NK cytoskeleton organization and activation","volume":"112","author":"Pallandre","year":"2008","journal-title":"Blood"},{"key":"B63","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/cdd.2013.48","article-title":"Danger signalling during cancer cell death: origins, plasticity and regulation","volume":"21","author":"Garg","year":"2014","journal-title":"Cell Death Differ"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3302959","article-title":"Gene therapy with\u00a0CX3CL1\/Fractalkine induces antitumor immunity to regress effectively mouse\u00a0hepatocellular carcinoma","volume":"14","author":"Tang","year":"2007","journal-title":"Gene Ther"},{"key":"B65","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3892\/mco.2012.30","article-title":"Antitumor immune activity by chemokine CX3CL1 in an orthotopic implantation of lung cancer model in vivo","volume":"1","author":"Kee","year":"2013","journal-title":"Mol Clin Oncol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200526042","article-title":"Antitumor immune response by CX3CL1 fractalkine gene transfer depends on both NK and T cells","volume":"35","author":"Xin","year":"2005","journal-title":"Eur J Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.97828","article-title":"CX3CR1 identifies PD-1 therapy\u2013responsive CD8+ T cells that withstand chemotherapy during cancer chemoimmunotherapy","volume":"3","author":"Yan","year":"2018","journal-title":"JCI Insight"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.22660","article-title":"Defective antitumor responses in CX3CR1-deficient mice","volume":"121","author":"Yu","year":"2007","journal-title":"Int J Cancer"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1002\/jso.23095","article-title":"High expression of CX3CL1 by tumor cells correlates with a good prognosis and increased tumor-infiltrating CD8+ T cells, natural killer cells, and dendritic cells in breast carcinoma","volume":"106","author":"Park","year":"2012","journal-title":"J Surg Oncol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3892\/ijo","article-title":"The high expression of Fractalkine results in a better prognosis for colorectal cancer patients","volume":"26","author":"Ohta","year":"2005","journal-title":"Int J Oncol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1501335","article-title":"The fractalkine-receptor axis improves human colorectal cancer prognosis by limiting tumor metastatic dissemination","volume":"196","author":"Erreni","year":"2016","journal-title":"J Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3892\/ol","article-title":"Increased CX3CL1 mRNA expression level is a positive prognostic factor in patients with lung adenocarcinoma","volume":"17","author":"Liu","year":"2019","journal-title":"Oncol Lett"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-008-9876-3","article-title":"Increased expression of fractalkine is correlated with a better prognosis and an increased number of both CD8+ T cells and natural killer cells in gastric adenocarcinoma","volume":"15","author":"Hyakudomi","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1111\/imcb.12225","article-title":"The R132H mutation in IDH1 promotes the recruitment of NK cells through CX3CL1\/CX3CR1 chemotaxis and is correlated with a better prognosis in gliomas","volume":"97","author":"Ren","year":"2019","journal-title":"Immunol Cell Biol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1002\/jso.20642","article-title":"Fractalkine-CX3CR1 axis regulates tumor cell cycle and deteriorates prognosis after radical resection for hepatocellular carcinoma","volume":"95","author":"Matsubara","year":"2007","journal-title":"J Surg Oncol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1396349\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T04:46:25Z","timestamp":1719809185000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1396349\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,1]]},"references-count":75,"alternative-id":["10.3389\/fimmu.2024.1396349"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1396349","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,1]]},"article-number":"1396349"}}